These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10084778)

  • 21. Effect of chronic renal failure and prednisolone on the growth hormone-insulin-like growth factor axis.
    Kapila P; Jones J; Rees L
    Pediatr Nephrol; 2001 Dec; 16(12):1099-104. PubMed ID: 11793109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal transplantation in the pediatric age].
    Ghio L; Garavaglia R
    Minerva Pediatr; 2003 Apr; 55(2):103-8. PubMed ID: 12754454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttransplant growth failure in children.
    Kelly DA
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S32-9. PubMed ID: 9377772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Glucocorticoids in pediatrics].
    Radmanović SZ
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():58-62. PubMed ID: 18193804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth after organ transplantation.
    Fuqua JS
    Semin Pediatr Surg; 2006 Aug; 15(3):162-9. PubMed ID: 16818137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.
    Tulipano G; Rossi E; Culler MD; Taylor JE; Bonadonna S; Locatelli V; Cocchi D; Giustina A
    Regul Pept; 2005 Feb; 125(1-3):85-92. PubMed ID: 15582718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of growth hormone in glucocorticoid-induced osteoporosis.
    Lombardi G; Colarusso S; Di Somma C; Guerra E; Tauchmanova L; Colao A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):38-42. PubMed ID: 18791350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone therapy in adults: rationales, results, and perspectives.
    Riedel M; Brabant G; Rieger K; von zur Mühlen A
    Exp Clin Endocrinol; 1994; 102(4):273-83. PubMed ID: 7813598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GH, IGF-I, and growth.
    Isaksson O
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth after renal transplantation in infancy or early childhood.
    Qvist E; Marttinen E; Rönnholm K; Antikainen M; Jalanko H; Sipilä I; Holmberg C
    Pediatr Nephrol; 2002 Jun; 17(6):438-43. PubMed ID: 12107809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The causes of the end of growth hormone treatment in children with chronic renal failure].
    Leszczyńiska B; Ziółkowska H; Majcher A; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():153-5. PubMed ID: 16898517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human growth hormone for children with renal failure.
    Tönshoff B; Fine RN
    Adv Ren Replace Ther; 1996 Jan; 3(1):37-47. PubMed ID: 8620367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroids and growth.
    Fine RN
    Kidney Int Suppl; 1993 Oct; 43():S59-61. PubMed ID: 7902467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects.
    Mauras N
    Horm Res; 2001; 56 Suppl 1():13-8. PubMed ID: 11786679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.
    Ulinski T; Cochat P
    Pediatr Nephrol; 2006 Jul; 21(7):903-9. PubMed ID: 16773400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.